4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-031172
Chief Technology Officer sold 20,000 shares at $9.92 ($198,400)
- Chief Technology Officer gave up 1,030 shares (to pay taxes)
- Chief Technology Officer acquired 2,642 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-05-18 | Option exercise | +2,642 | 8,125,445 | D | ||
| Yan Ming Chief Technology Officer | 2022-05-18 | Shares withheld for taxes | −1,030 | $9.65 | $9,940 | 8,124,415 | D |
| Yan Ming Chief Technology Officer | 2022-05-19 | Sale | −20,000 | $9.92 | $198,400 | 8,104,415 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2022-05-18 | Option exercise · Restricted Stock Units | −2,642 | 29,066 | D | ||
| Open-market sales · 20,000 sh · avg $9.92 · $198,400 | |||||||
Loading xslF345X03/doc4.xml…